Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
60
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

Kirsten Y Westerhout1 Pharmerit BV, Marten Meesweg, Rotterdam, the Netherlands
,
Walter Bouwmeester1 Pharmerit BV, Marten Meesweg, Rotterdam, the Netherlands
,
Inge Duchesne2 Janssen EMEA, Turnhoutseweg, Beerse, Belgium
,
Marta Pisini2 Janssen EMEA, Turnhoutseweg, Beerse, Belgium
,
Marjanne A Piena1 Pharmerit BV, Marten Meesweg, Rotterdam, the Netherlands
,
Francesco Damele3 Janssen-Cilag SpA, Via Michelangelo Buonarroti, Cologno Monzese, Italy
,
Beatrice Gueron2 Janssen EMEA, Turnhoutseweg, Beerse, Belgium
,
Maarten Treur1 Pharmerit BV, Marten Meesweg, Rotterdam, the Netherlands
&
Jonathan Belsey4 JB Medical Ltd, Old Brickworks, Little Cornard, United KingdomCorrespondence[email protected]
 show all
Pages 163-172 | Published online: 27 Feb 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.